Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Some nutrients and antioxidants may improve skin and hair health, but more research is needed to confirm these benefits.

The document lists various dermatology topics, treatments, and diagnostic methods.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Hirsutism can lower a woman's quality of life, causing emotional distress and affecting social and work opportunities.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Alopecia areata in infants may be more common than previously thought.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

TrichoScan is reliable for counting and measuring hair density but may not accurately assess hair types in women with hair loss.

Hair loss can cause significant social and emotional issues, especially for women and young men.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Finasteride and low-level laser therapy are similarly effective for frontal pattern hair loss.

Minoxidil and finasteride combined can effectively treat hair loss.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Primary health physicians in Saudi Arabia need better guidelines for treating hair loss with vitamins and minerals.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Minoxidil and finasteride are effective for male hair loss; minoxidil also helps female hair loss, with some treatments needing more research.

Hormonal therapies, especially antiandrogens, can help manage Hidradenitis Suppurativa.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

Eating a Mediterranean diet and taking certain supplements may improve symptoms of PCOS.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.